Ethic Inc. Amgen Inc Transaction History

Ethic Inc.

$4.83 Billion
Q4 2024

A detailed history of Ethic Inc. transactions in Amgen Inc stock. As of the latest transaction made, Ethic Inc. holds 49,830 shares of AMGN stock, worth $15.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

49,830

Previous 41,437 20.25%

Holding current value

$15.4 Million

Previous $13.4 Million 2.73%

% of portfolio

0.27%

Previous 0.34%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $2.17 Million - $2.76 Million	8,393 Added 20.25%	49,830 $13 Million
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $625,566 - $682,182	-2,022 Reduced 4.65%	41,437 $13.4 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $531,280 - $645,644	2,022 Added 4.88%	43,459 $13.6 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $73,670 - $88,929	-274 Reduced 0.66%	41,437 $11.8 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $435,457 - $491,247	1,703 Added 4.26%	41,711 $12 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $2.17 Million - $2.69 Million	9,924 Added 32.99%	40,008 $10.8 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $639,595 - $756,309	-2,985 Reduced 9.03%	30,084 $6.68 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $2.06 Million - $2.51 Million	9,109 Added 38.02%	33,069 $7.99 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $567,536 - $721,122	2,478 Added 11.54%	23,960 $6.29 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $658,565 - $742,742	-2,934 Reduced 12.02%	21,482 $4.84 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $2.89 Million - $3.21 Million	-12,522 Reduced 33.9%	24,416 $5.94 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.94 Million - $2.15 Million	8,848 Added 31.5%	36,938 $8.93 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $943,088 - $1.08 Million	4,742 Added 20.31%	28,090 $6.32 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $713,014 - $835,383	3,359 Added 16.8%	23,348 $4.97 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $1.35 Million - $1.49 Million	5,761 Added 40.49%	19,989 $4.87 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1 Million - $1.17 Million	4,524 Added 46.62%	14,228 $3.54 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $518,230 - $617,119	2,395 Added 32.77%	9,704 $2.23 Million
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $492,295 - $547,473	2,098 Added 40.26%	7,309 $1.86 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $132,334 - $162,393	669 Added 14.73%	5,211 $1.23 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $78,545 - $104,172	431 Added 10.48%	4,542 $921,000
Q4 2019 May 22, 2020	BUY	$189.21 - $243.2 $108,228 - $139,110	572 Added 16.16%	4,111 $991,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $669,614 - $860,684	3,539 New	3,539 $853,000

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account